Abstract:One of the major applications of generative models for drug discovery targets the lead-optimization phase. During the optimization of a lead series, it is common to have scaffold constraints imposed on the structure of the molecules designed. Without enforcing such constraints, the probability of generating molecules with the required scaffold is extremely low and hinders the practicality of generative models for de novo drug design. To tackle this issue, we introduce a new algorithm, named SAMOA (Scaffold Constrained Molecular Generation), to perform scaffold-constrained in silico molecular design. We build on the well-known SMILES-based Recurrent Neural Network (RNN) generative model, with a modified sampling procedure to achieve scaffold-constrained generation. We directly benefit from the associated reinforcement learning methods, allowing to design molecules optimized for different properties while exploring only the relevant chemical space. We showcase the method's ability to perform scaffold-constrained generation on various tasks: designing novel molecules around scaffolds extracted from SureChEMBL chemical series, generating novel active molecules on the Dopamine Receptor D2 (DRD2) target, and finally, designing predicted actives on the MMP-12 series, an industrial lead-optimization project.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.0c01015?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.0c01015</a>.Availability of data used to train models and run experiments, algorithmic description of naive policy masking (Algorithm S1), algorithmic description of hill-climbing (Algorithm S2), examples of molecules obtained after sampling the core of fexofenadine (Figure S1 for sampled molecules, Figure S2 for the original molecule), examples of molecules obtained after replacing the ring system of fexofenadine (Figure S3), distributions of ClogP, Molecular Weight, QED and SAS for reference molecules, molecules where a branched decoration was sampled, and molecules where the core was sampled (Figure S4), the 17 validation scaffolds from SureChEMBL (Figure S5), histograms of Tanimoto similarities between generated molecules for each of the DRD2 scaffolds (Figure S6), and unicity of sampled decorations for each open positions of the DRD2 scaffolds (Figure S7) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01015/suppl_file/ci0c01015_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Population-based de novo molecule generation, using grammatical evolution

Structure-Based de Novo Molecular Generator Combined with Artificial Intelligence and Docking Simulations

Human-level molecular optimization driven by mol-gene evolution

Advances in Deep Learning-Based 3D Molecular Generative Models

Multi-Objective De Novo Drug Design with Conditional Graph Generative Model

Faster and more diverse de novo molecular optimization with double-loop reinforcement learning using augmented SMILES

Molecular generation strategy and optimization based on A2C reinforcement learning in de novo drug design

FragGT: Fragment-based evolutionary molecule generation with gene types

Molecular De Novo Design through Deep Reinforcement Learning

Diversity oriented Deep Reinforcement Learning for targeted molecule generation

Gx2Mol: De Novo Generation of Hit-like Molecules from Gene Expression Profiles via Deep Learning

Seq2Mol: Automatic design of de novo molecules conditioned by the target protein sequences through deep neural networks

Scaffold-Constrained Molecular Generation

EvoMol: a flexible and interpretable evolutionary algorithm for unbiased de novo molecular generation

Machine learning-aided generative molecular design

Learning on topological surface and geometric structure for 3D molecular generation

Electron-density informed effective and reliable de novo molecular design and lead optimization with ED2Mol

Guided Multi-objective Generative AI to Enhance Structure-based Drug Design

ChemistGA: A Chemical Synthesizable Accessible Molecular Generation Algorithm for Real-World Drug Discovery

A Transformer-based Generative Model for De Novo Molecular Design

Goal-directed molecule generation with fine-tuning by policy gradient